Is ZHYBF or GBDC a better dividend investment in 2026?

ZHYBF currently yields 99.01% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: ZHYBF offers higher current income.

What is the dividend yield difference between ZHYBF and GBDC?

ZHYBF has a forward dividend yield of 99.01% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 87.15 percentage points.

Home › Compare › ZHYBF vs GBDC

ZHYBF vs GBDC: Dividend Comparison 2026

ZHYBF yields 99.01% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBDC wins by $17.11M in total portfolio value· pulled ahead in Year 9

INVESTMENT

TIME HORIZON10 years

ZHYBF

● Live price

99.01%

Share price

$2.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.74M

Annual income

$1,252,449.65

Full ZHYBF calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — ZHYBF vs GBDC

📍 GBDC pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZHYBF	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZHYBF + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZHYBF pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZHYBF

Annual income on $10K today (after 15% tax)

$8,415.84/yr

After 10yr DRIP, annual income (after tax)

$1,064,582.20/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, GBDC beats the other by $12,918,541.55/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZHYBF + GBDC for your $10,000?

ZHYBF: 50%GBDC: 50%

100% GBDC50/50100% ZHYBF

Portfolio after 10yr

$12.30M

Annual income

$8,851,591.74/yr

Blended yield

71.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

ZHYBF

No analyst data

Altman Z

5.7

Piotroski

7/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZHYBF buys

GBDC buys

No recent congressional trades found for ZHYBF or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZHYBFGBDC

Forward yield	99.01% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$3.74M	$20.85M ✓
Annual income after 10y	$1,252,449.65	$16,450,733.83 ✓
Total dividends collected	$3.34M	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: ZHYBF vs GBDC ($10,000, DRIP)

Year	ZHYBF Portfolio	ZHYBF Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1	$20,601	$9,900.99	$12,492	$1,791.70	+$8.1K → ZHYBF
2	$41,106	$19,062.64	$16,527	$3,160.58	+$24.6K → ZHYBF
3	$79,531	$35,547.83	$23,588	$5,904.90	+$55.9K → ZHYBF
4	$149,376	$64,278.14	$37,141	$11,901.65	+$112.2K → ZHYBF
5	$272,663	$112,830.11	$66,205	$26,463.38	+$206.5K → ZHYBF
6	$484,229	$192,479.92	$137,452	$66,612.65	+$346.8K → ZHYBF
7	$837,593	$319,467.53	$342,372	$195,298.53	+$495.2K → ZHYBF
8	$1,412,670	$516,446.07	$1,053,292	$686,954.33	+$359.4K → ZHYBF
9← crossover	$2,325,603	$814,046.39	$4,111,439	$2,984,416.95	$1.79M → GBDC
10	$3,740,845	$1,252,449.65	$20,849,974	$16,450,733.83	$17.11M → GBDC

ZHYBF vs GBDC: Complete Analysis 2026

ZHYBF — Stock

Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company's products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life's NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited is based in Wanchai, Hong Kong.

Full ZHYBF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this ZHYBF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZHYBF vs SCHD ZHYBF vs JEPI ZHYBF vs O ZHYBF vs KO ZHYBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.